SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 81 filers reported holding SYNERON MEDICAL LTD in Q2 2017. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,364,000 | +16.1% | 215,828 | +11.8% | 0.00% | – |
| Q1 2017 | $2,036,000 | +296.1% | 192,978 | +214.3% | 0.00% | – |
| Q4 2016 | $514,000 | +2134.8% | 61,390 | +1817.2% | 0.00% | – |
| Q3 2016 | $23,000 | -28.1% | 3,202 | -24.4% | 0.00% | – |
| Q2 2016 | $32,000 | -17.9% | 4,237 | -22.3% | 0.00% | – |
| Q1 2016 | $39,000 | -2.5% | 5,451 | +3.9% | 0.00% | – |
| Q4 2015 | $40,000 | -24.5% | 5,246 | -30.0% | 0.00% | – |
| Q3 2015 | $53,000 | -76.4% | 7,489 | -64.7% | 0.00% | – |
| Q2 2015 | $225,000 | -76.9% | 21,212 | -73.0% | 0.00% | – |
| Q1 2015 | $973,000 | +399.0% | 78,534 | +276.0% | 0.00% | – |
| Q4 2014 | $195,000 | +66.7% | 20,884 | +78.4% | 0.00% | – |
| Q3 2014 | $117,000 | -33.9% | 11,703 | -31.8% | 0.00% | – |
| Q2 2014 | $177,000 | -12.4% | 17,164 | +5.3% | 0.00% | – |
| Q1 2014 | $202,000 | +30.3% | 16,293 | +28.7% | 0.00% | – |
| Q4 2013 | $155,000 | -1.9% | 12,663 | -30.1% | 0.00% | – |
| Q2 2013 | $158,000 | – | 18,115 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Senvest Management, LLC | 2,988,261 | $25,759,000 | 2.86% |
| NORTH TIDE CAPITAL, LLC | 2,150,000 | $18,533,000 | 1.94% |
| HOURGLASS CAPITAL, LLC | 838,900 | $7,231,000 | 1.26% |
| Baupost Group | 4,000,000 | $34,480,000 | 0.98% |
| DAFNA Capital Management LLC | 90,947 | $784,000 | 0.86% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 573,108 | $4,940,000 | 0.77% |
| Visium Asset Management, LP | 3,405,000 | $29,351,000 | 0.67% |
| PERRITT CAPITAL MANAGEMENT INC | 380,000 | $3,276,000 | 0.64% |
| Leonard Capital Management, Inc. | 112,109 | $966,000 | 0.38% |
| BRANDES INVESTMENT PARTNERS, LP | 1,765,018 | $15,214,000 | 0.20% |